相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intestinal IL-33 promotes platelet activity or neutrophil recruitment during acute inflammation
Zuojia Chen et al.
BLOOD (2022)
In Vitro Evidence for the Role of Cytokine Storm in the Generation of Stent Thrombosis in COVID-19 Patients
Paul A. Gurbel et al.
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2022)
COVID-19 infection: an overview on cytokine storm and related interventions
Soheila Montazersaheb et al.
VIROLOGY JOURNAL (2022)
Involvement of Il-33 in the Pathogenesis and Prognosis of Major Respiratory Viral Infections: Future Perspectives for Personalized Therapy
Giuseppe Murdaca et al.
BIOMEDICINES (2022)
Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine
Corinne Cayrol et al.
CYTOKINE (2022)
Thromboembolic Disease and Cardiac Thrombotic Complication in COVID-19: A Systematic Review
Francesco Nappi et al.
METABOLITES (2022)
Understanding COVID-19-associated coagulopathy
Edward M. Conway et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Lung megakaryocytes are immune modulatory cells
Daphne N. Pariser et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The Paradigm Change of IL-33 in Vascular Biology
Svitlana Demyanets et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors
Leonardo Cristinziano et al.
CELLS (2021)
Monocytes and macrophages in COVID-19: Friends and foes
Sepideh Meidaninikjeh et al.
LIFE SCIENCES (2021)
Prevalence and Determinants of Fatigue after COVID-19 in Non-Hospitalized Subjects: A Population-Based Study
Knut Stavem et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
IL-33 in COVID-19: friend or foe?
Yuejin Liang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Basophils and Mast Cells in COVID-19 Pathogenesis
Giuseppe Murdaca et al.
CELLS (2021)
IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding
Sofija Sekulic Markovic et al.
FRONTIERS IN MEDICINE (2021)
IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
Michal A. Stanczak et al.
NATURE COMMUNICATIONS (2021)
Long COVID and Post-infective Fatigue Syndrome: A Review
Carolina X. Sandler et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Alarmins, COVID-19 and comorbidities
Eleonora Di Salvo et al.
ANNALS OF MEDICINE (2021)
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Aldo Bonaventura et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Genetic Deficiency of Interferon-γ Reveals Interferon-γ-Independent Manifestations of Murine Hemophagocytic Lymphohistiocytosis
Thomas N. Burn et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS
Shruti Chaturvedi et al.
BLOOD (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
TGF-β induces ST2 and programs ILC2 development
Li Wang et al.
NATURE COMMUNICATIONS (2020)
COVID-19 Autopsies, Oklahoma, USA
Lisa M. Barton et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Yan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications
James D. McFadyen et al.
CIRCULATION RESEARCH (2020)
Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications
Alessandro Allegra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
Alessandro Allegra et al.
ANNALS OF HEMATOLOGY (2020)
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Robert Verity et al.
LANCET INFECTIOUS DISEASES (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Lymphopenia during the COVID-19 infection: What it shows and what can be learned
Soheil Tavakolpour et al.
IMMUNOLOGY LETTERS (2020)
Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
Gaetano Zizzo et al.
LANCET RHEUMATOLOGY (2020)
Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection
Masaaki Miyazawa
INFLAMMATION AND REGENERATION (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19
Zhikun Zeng et al.
BIOMARKERS IN MEDICINE (2020)
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
Yong Xiong et al.
EMERGING MICROBES & INFECTIONS (2020)
IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases
Giuseppe Murdaca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
Ben C. L. Chan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
Corinne Cayrol et al.
IMMUNOLOGICAL REVIEWS (2018)
Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate
Christina Li-Ping Thio et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
The pathogenicity of IL-33 on steroid-resistant eosinophilic inflammation via the activation of memory-type ST2(+)CD4(+) T cells
Kiyoshi Hirahara et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33
Corinne Cayrol et al.
NATURE IMMUNOLOGY (2018)
Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage
Ian C. Scott et al.
SCIENTIFIC REPORTS (2018)
IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets
Stefan Stojkovic et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation
Stefan Stojkovic et al.
SCIENTIFIC REPORTS (2016)
Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
Ari B. Molofsky et al.
IMMUNITY (2015)
Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection
Jennifer Kearley et al.
IMMUNITY (2015)
Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences
Olav Sundnes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
IL-33 is regulated by TNF-α in normal and psoriatic skin
Anna Balato et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
Svitlana Demyanets et al.
CYTOKINE (2014)
Interleukin (IL)-33: New Therapeutic Target for Atopic Diseases
Takeshi Nabe
JOURNAL OF PHARMACOLOGICAL SCIENCES (2014)
Interleukin-33 induces urokinase in human endothelial cells?possible impact on angiogenesis
S. Stojkovic et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
Svitlana Demyanets et al.
PLOS ONE (2014)
Pre-discharge risk stratification in unselected STEMI: Is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?
Onkar S. Dhillon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue
M. Zeyda et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma
Sejal Saglani et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease
Derek E. Byers et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33-LacZ Gene Trap Reporter Strain
Melanie Pichery et al.
JOURNAL OF IMMUNOLOGY (2012)
Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice
Koubun Yasuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Emma Lefrancais et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Endothelium-role in regulation of coagulation and inflammation
Victor W. M. van Hinsbergh
SEMINARS IN IMMUNOPATHOLOGY (2012)
Interleukin-33 Induces Expression of Adhesion Molecules and Inflammatory Activation in Human Endothelial Cells and in Human Atherosclerotic Plaques
Svitlana Demyanets et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells
Yoshiki Yanagawa et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells
Shinsuke Aoki et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
Jose C. Alves-Filho et al.
NATURE MEDICINE (2010)
Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
Yeon-Sook Choi et al.
BLOOD (2009)
The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production
Elvire Bourgeois et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket
Lucie Roussel et al.
EMBO REPORTS (2008)
IL-33 amplifies both Th1-and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Molly D. Smithgall et al.
INTERNATIONAL IMMUNOLOGY (2008)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Interactions between coagulation and inflammation
SM Opal
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
分享论文
